Industry Research Reports

Home > Reports > Medical Care > Acromegaly - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Acromegaly - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 113 Pages

Report ld: 2339317

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.

The global market for Acromegaly was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Acromegaly, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acromegaly by region & country, by Type, and by Application.

The Acromegaly market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acromegaly.

Market Segmentation

Report Metric
Details
Report Title
Acromegaly - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Acromegaly Companies Covered
Novartis, Aegis Therapeutics, Chiasma, Crinetics Pharmaceuticals, Daewoong Pharmaceutical, Peptron, Silence Therapeutics, Strongbridge Biopharma, Amryt Pharma, Foresee Pharmaceuticals, Glide Pharmaceutical, Ionis Pharmaceuticals, Ipsen
Global Acromegaly Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Acromegaly Market, Segment by Type
Somatostatin Analogues

Dopamine Agonists

Growth Hormone Receptor Antagonists

Other
Global Acromegaly Market, Segment by Application
Hospitals

Clinics
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Acromegaly manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Acromegaly in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Acromegaly in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Acromegaly Product Introduction
    1.2 Global Acromegaly Market Size Forecast
    1.3 Acromegaly Market Trends & Drivers
        1.3.1 Acromegaly Industry Trends
        1.3.2 Acromegaly Market Drivers & Opportunity
        1.3.3 Acromegaly Market Challenges
        1.3.4 Acromegaly Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Acromegaly Players Revenue Ranking (2023)
    2.2 Global Acromegaly Revenue by Company (2019-2024)
    2.3 Key Companies Acromegaly Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Acromegaly Product Offered
    2.5 Key Companies Time to Begin Mass Production of Acromegaly
    2.6 Acromegaly Market Competitive Analysis
        2.6.1 Acromegaly Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Acromegaly Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Somatostatin Analogues
        3.1.2 Dopamine Agonists
        3.1.3 Growth Hormone Receptor Antagonists
        3.1.4 Other
    3.2 Global Acromegaly Sales Value by Type
        3.2.1 Global Acromegaly Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Acromegaly Sales Value, by Type (2019-2030)
        3.2.3 Global Acromegaly Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
    4.2 Global Acromegaly Sales Value by Application
        4.2.1 Global Acromegaly Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Acromegaly Sales Value, by Application (2019-2030)
        4.2.3 Global Acromegaly Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Acromegaly Sales Value by Region
        5.1.1 Global Acromegaly Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Acromegaly Sales Value by Region (2019-2024)
        5.1.3 Global Acromegaly Sales Value by Region (2025-2030)
        5.1.4 Global Acromegaly Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Acromegaly Sales Value, 2019-2030
        5.2.2 North America Acromegaly Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Acromegaly Sales Value, 2019-2030
        5.3.2 Europe Acromegaly Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Acromegaly Sales Value, 2019-2030
        5.4.2 Asia Pacific Acromegaly Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Acromegaly Sales Value, 2019-2030
        5.5.2 South America Acromegaly Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Acromegaly Sales Value, 2019-2030
        5.6.2 Middle East & Africa Acromegaly Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Acromegaly Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Acromegaly Sales Value
    6.3 United States
        6.3.1 United States Acromegaly Sales Value, 2019-2030
        6.3.2 United States Acromegaly Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Acromegaly Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Acromegaly Sales Value, 2019-2030
        6.4.2 Europe Acromegaly Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Acromegaly Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Acromegaly Sales Value, 2019-2030
        6.5.2 China Acromegaly Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Acromegaly Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Acromegaly Sales Value, 2019-2030
        6.6.2 Japan Acromegaly Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Acromegaly Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Acromegaly Sales Value, 2019-2030
        6.7.2 South Korea Acromegaly Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Acromegaly Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Acromegaly Sales Value, 2019-2030
        6.8.2 Southeast Asia Acromegaly Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Acromegaly Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Acromegaly Sales Value, 2019-2030
        6.9.2 India Acromegaly Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Acromegaly Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Profile
        7.1.2 Novartis Main Business
        7.1.3 Novartis Acromegaly Products, Services and Solutions
        7.1.4 Novartis Acromegaly Revenue (US$ Million) & (2019-2024)
        7.1.5 Novartis Recent Developments
    7.2 Aegis Therapeutics
        7.2.1 Aegis Therapeutics Profile
        7.2.2 Aegis Therapeutics Main Business
        7.2.3 Aegis Therapeutics Acromegaly Products, Services and Solutions
        7.2.4 Aegis Therapeutics Acromegaly Revenue (US$ Million) & (2019-2024)
        7.2.5 Aegis Therapeutics Recent Developments
    7.3 Chiasma
        7.3.1 Chiasma Profile
        7.3.2 Chiasma Main Business
        7.3.3 Chiasma Acromegaly Products, Services and Solutions
        7.3.4 Chiasma Acromegaly Revenue (US$ Million) & (2019-2024)
        7.3.5 Crinetics Pharmaceuticals Recent Developments
    7.4 Crinetics Pharmaceuticals
        7.4.1 Crinetics Pharmaceuticals Profile
        7.4.2 Crinetics Pharmaceuticals Main Business
        7.4.3 Crinetics Pharmaceuticals Acromegaly Products, Services and Solutions
        7.4.4 Crinetics Pharmaceuticals Acromegaly Revenue (US$ Million) & (2019-2024)
        7.4.5 Crinetics Pharmaceuticals Recent Developments
    7.5 Daewoong Pharmaceutical
        7.5.1 Daewoong Pharmaceutical Profile
        7.5.2 Daewoong Pharmaceutical Main Business
        7.5.3 Daewoong Pharmaceutical Acromegaly Products, Services and Solutions
        7.5.4 Daewoong Pharmaceutical Acromegaly Revenue (US$ Million) & (2019-2024)
        7.5.5 Daewoong Pharmaceutical Recent Developments
    7.6 Peptron
        7.6.1 Peptron Profile
        7.6.2 Peptron Main Business
        7.6.3 Peptron Acromegaly Products, Services and Solutions
        7.6.4 Peptron Acromegaly Revenue (US$ Million) & (2019-2024)
        7.6.5 Peptron Recent Developments
    7.7 Silence Therapeutics
        7.7.1 Silence Therapeutics Profile
        7.7.2 Silence Therapeutics Main Business
        7.7.3 Silence Therapeutics Acromegaly Products, Services and Solutions
        7.7.4 Silence Therapeutics Acromegaly Revenue (US$ Million) & (2019-2024)
        7.7.5 Silence Therapeutics Recent Developments
    7.8 Strongbridge Biopharma
        7.8.1 Strongbridge Biopharma Profile
        7.8.2 Strongbridge Biopharma Main Business
        7.8.3 Strongbridge Biopharma Acromegaly Products, Services and Solutions
        7.8.4 Strongbridge Biopharma Acromegaly Revenue (US$ Million) & (2019-2024)
        7.8.5 Strongbridge Biopharma Recent Developments
    7.9 Amryt Pharma
        7.9.1 Amryt Pharma Profile
        7.9.2 Amryt Pharma Main Business
        7.9.3 Amryt Pharma Acromegaly Products, Services and Solutions
        7.9.4 Amryt Pharma Acromegaly Revenue (US$ Million) & (2019-2024)
        7.9.5 Amryt Pharma Recent Developments
    7.10 Foresee Pharmaceuticals
        7.10.1 Foresee Pharmaceuticals Profile
        7.10.2 Foresee Pharmaceuticals Main Business
        7.10.3 Foresee Pharmaceuticals Acromegaly Products, Services and Solutions
        7.10.4 Foresee Pharmaceuticals Acromegaly Revenue (US$ Million) & (2019-2024)
        7.10.5 Foresee Pharmaceuticals Recent Developments
    7.11 Glide Pharmaceutical
        7.11.1 Glide Pharmaceutical Profile
        7.11.2 Glide Pharmaceutical Main Business
        7.11.3 Glide Pharmaceutical Acromegaly Products, Services and Solutions
        7.11.4 Glide Pharmaceutical Acromegaly Revenue (US$ Million) & (2019-2024)
        7.11.5 Glide Pharmaceutical Recent Developments
    7.12 Ionis Pharmaceuticals
        7.12.1 Ionis Pharmaceuticals Profile
        7.12.2 Ionis Pharmaceuticals Main Business
        7.12.3 Ionis Pharmaceuticals Acromegaly Products, Services and Solutions
        7.12.4 Ionis Pharmaceuticals Acromegaly Revenue (US$ Million) & (2019-2024)
        7.12.5 Ionis Pharmaceuticals Recent Developments
    7.13 Ipsen
        7.13.1 Ipsen Profile
        7.13.2 Ipsen Main Business
        7.13.3 Ipsen Acromegaly Products, Services and Solutions
        7.13.4 Ipsen Acromegaly Revenue (US$ Million) & (2019-2024)
        7.13.5 Ipsen Recent Developments

 8 Industry Chain Analysis
    8.1 Acromegaly Industrial Chain
    8.2 Acromegaly Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Acromegaly Sales Model
        8.5.2 Sales Channel
        8.5.3 Acromegaly Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Acromegaly Market Trends
    Table 2. Acromegaly Market Drivers & Opportunity
    Table 3. Acromegaly Market Challenges
    Table 4. Acromegaly Market Restraints
    Table 5. Global Acromegaly Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Acromegaly Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Acromegaly Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Acromegaly Product Type
    Table 9. Key Companies Time to Begin Mass Production of Acromegaly
    Table 10. Global Acromegaly Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acromegaly as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Acromegaly Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Acromegaly Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Acromegaly Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Acromegaly Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Acromegaly Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Acromegaly Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Acromegaly Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Acromegaly Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Acromegaly Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Acromegaly Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Acromegaly Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Acromegaly Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Acromegaly Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Acromegaly Sales Value by Region (2019-2024) & (%)
    Table 27. Global Acromegaly Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Acromegaly Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Acromegaly Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Acromegaly Sales Value, (2025-2030) & (US$ Million)
    Table 31. Novartis Basic Information List
    Table 32. Novartis Description and Business Overview
    Table 33. Novartis Acromegaly Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Acromegaly Business of Novartis (2019-2024)
    Table 35. Novartis Recent Developments
    Table 36. Aegis Therapeutics Basic Information List
    Table 37. Aegis Therapeutics Description and Business Overview
    Table 38. Aegis Therapeutics Acromegaly Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Acromegaly Business of Aegis Therapeutics (2019-2024)
    Table 40. Aegis Therapeutics Recent Developments
    Table 41. Chiasma Basic Information List
    Table 42. Chiasma Description and Business Overview
    Table 43. Chiasma Acromegaly Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Acromegaly Business of Chiasma (2019-2024)
    Table 45. Chiasma Recent Developments
    Table 46. Crinetics Pharmaceuticals Basic Information List
    Table 47. Crinetics Pharmaceuticals Description and Business Overview
    Table 48. Crinetics Pharmaceuticals Acromegaly Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Acromegaly Business of Crinetics Pharmaceuticals (2019-2024)
    Table 50. Crinetics Pharmaceuticals Recent Developments
    Table 51. Daewoong Pharmaceutical Basic Information List
    Table 52. Daewoong Pharmaceutical Description and Business Overview
    Table 53. Daewoong Pharmaceutical Acromegaly Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Acromegaly Business of Daewoong Pharmaceutical (2019-2024)
    Table 55. Daewoong Pharmaceutical Recent Developments
    Table 56. Peptron Basic Information List
    Table 57. Peptron Description and Business Overview
    Table 58. Peptron Acromegaly Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Acromegaly Business of Peptron (2019-2024)
    Table 60. Peptron Recent Developments
    Table 61. Silence Therapeutics Basic Information List
    Table 62. Silence Therapeutics Description and Business Overview
    Table 63. Silence Therapeutics Acromegaly Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Acromegaly Business of Silence Therapeutics (2019-2024)
    Table 65. Silence Therapeutics Recent Developments
    Table 66. Strongbridge Biopharma Basic Information List
    Table 67. Strongbridge Biopharma Description and Business Overview
    Table 68. Strongbridge Biopharma Acromegaly Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Acromegaly Business of Strongbridge Biopharma (2019-2024)
    Table 70. Strongbridge Biopharma Recent Developments
    Table 71. Amryt Pharma Basic Information List
    Table 72. Amryt Pharma Description and Business Overview
    Table 73. Amryt Pharma Acromegaly Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Acromegaly Business of Amryt Pharma (2019-2024)
    Table 75. Amryt Pharma Recent Developments
    Table 76. Foresee Pharmaceuticals Basic Information List
    Table 77. Foresee Pharmaceuticals Description and Business Overview
    Table 78. Foresee Pharmaceuticals Acromegaly Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Acromegaly Business of Foresee Pharmaceuticals (2019-2024)
    Table 80. Foresee Pharmaceuticals Recent Developments
    Table 81. Glide Pharmaceutical Basic Information List
    Table 82. Glide Pharmaceutical Description and Business Overview
    Table 83. Glide Pharmaceutical Acromegaly Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Acromegaly Business of Glide Pharmaceutical (2019-2024)
    Table 85. Glide Pharmaceutical Recent Developments
    Table 86. Ionis Pharmaceuticals Basic Information List
    Table 87. Ionis Pharmaceuticals Description and Business Overview
    Table 88. Ionis Pharmaceuticals Acromegaly Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Acromegaly Business of Ionis Pharmaceuticals (2019-2024)
    Table 90. Ionis Pharmaceuticals Recent Developments
    Table 91. Ipsen Basic Information List
    Table 92. Ipsen Description and Business Overview
    Table 93. Ipsen Acromegaly Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Acromegaly Business of Ipsen (2019-2024)
    Table 95. Ipsen Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Acromegaly Downstream Customers
    Table 99. Acromegaly Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Acromegaly Product Picture
    Figure 2. Global Acromegaly Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Acromegaly Sales Value (2019-2030) & (US$ Million)
    Figure 4. Acromegaly Report Years Considered
    Figure 5. Global Acromegaly Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Acromegaly Revenue in 2023
    Figure 7. Acromegaly Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Somatostatin Analogues Picture
    Figure 9. Dopamine Agonists Picture
    Figure 10. Growth Hormone Receptor Antagonists Picture
    Figure 11. Other Picture
    Figure 12. Global Acromegaly Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Acromegaly Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Clinics
    Figure 16. Global Acromegaly Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Acromegaly Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Acromegaly Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Acromegaly Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Acromegaly Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Acromegaly Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Acromegaly Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Acromegaly Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Acromegaly Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Acromegaly Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Acromegaly Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Acromegaly Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Acromegaly Sales Value (%), (2019-2030)
    Figure 29. United States Acromegaly Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Acromegaly Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Acromegaly Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Acromegaly Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Acromegaly Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Acromegaly Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Acromegaly Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Acromegaly Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Acromegaly Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Acromegaly Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Acromegaly Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Acromegaly Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Acromegaly Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Acromegaly Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Acromegaly Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Acromegaly Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Acromegaly Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Acromegaly Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Acromegaly Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Acromegaly Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Acromegaly Sales Value by Application (%), 2023 VS 2030
    Figure 50. Acromegaly Industrial Chain
    Figure 51. Acromegaly Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.

The global market for Acromegaly was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Acromegaly, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acromegaly by region & country, by Type, and by Application.

The Acromegaly market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acromegaly.

Market Segmentation